Kaplan–Meier survival analysis of NAFLD/NASH patients to mortality or liver transplant by liver disease severity. Note: Patient groups are not mutually exclusive. NAFLD, non-alcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; CC, compensated cirrhosis; DCC, decompensated cirrhosis; HCC, hepatocellular carcinoma; NAFLD/NASH N = 125,052, CC N = 1491, DCC N = 7846, HCC N = 1144.